Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...
CAR T-cell therapy has been hugely successful in treating certain types of tumours, and stiffening up cancer cells beforehand ...
Cancer cells display aberrant glycosylation on cell surface proteins, but developing high-affinity antibodies against glycans for potential immunotherapies has not been feasible. Now, Zhou et al.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results